WHO ICTRP trial
Study on clinical efficacy of Qidong Huoxue Yin in the treatment of acute lung…
ChiCTR2100050170 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2100050170 |
|---|---|
| Public title | Study on clinical efficacy of Qidong Huoxue Yin in the treatment of acute lung injury |
| Scientific title | Study on clinical efficacy of Qidong Huoxue Yin in the treatment of acute lung injury |
| Primary sponsor | The Second Affiliated Hospital of Zhengjiang University of Chinese Medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | acute lung injury |
| Interventions | experimental group:routine combined therapy+ Qidong Huoxue Yin;control group:routine combined therapy |
| Registration date | Aug 19, 2021 |
| Target size | experimental group:40;control group:40 |
| Secondary IDs | ChiMCTR2100005190 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: